drugset / Trial / NCT02835586

STREAMER : STent Restenosis And MEdicaments Release

NCT02835586 ↗

Phase 3 Completed 15 enrolled Hospices Civils de Lyon
NaSingle-groupOpen-labelTreatment

Summary

It is a pilot study to evaluate the feasibility and the efficiency of local delivery of paclitaxel after stenting of long femoropopliteal arterial lesions TASC C and D before the realization of a large randomized multicentric study. Patients concerned are in critical ischemia.

Timeline

Start
2013-05
Primary completion
2015-11
Completion
2015-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Paclitaxel Small molecule — Other

Indications